Sign up to save your podcasts
Or
Share A Stem Cell-Derived Treatment for T1D
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Stem Cell-Derived Treatment for T1D
We love to hear from our listeners. Send us a message.
Sernova Corp. is a clinical-stage regenerative therapies company currently focused on insulin-dependent diabetes. CEO and President, Philip Toleikis, Ph.D., details the company's on-going clinical trial to treat Type 1 diabetes (T1D) as well as the very real potential to progress from simply masking symptoms to having a functional cure for T1D. Toleikis also provides his take on the near-term future of regenerative medicine.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Sernova Corp. is a clinical-stage regenerative therapies company currently focused on insulin-dependent diabetes. CEO and President, Philip Toleikis, Ph.D., details the company's on-going clinical trial to treat Type 1 diabetes (T1D) as well as the very real potential to progress from simply masking symptoms to having a functional cure for T1D. Toleikis also provides his take on the near-term future of regenerative medicine.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
760 Listeners
HBR IdeaCast
1,871 Listeners
Planet Money
30,675 Listeners
Motley Fool Money
3,191 Listeners
Freakonomics Radio
32,105 Listeners
The Knowledge Project with Shane Parrish
2,671 Listeners
Immune
268 Listeners
The Readout Loud
317 Listeners
BioCentury This Week
30 Listeners
People I (Mostly) Admire
2,119 Listeners
Raising Health
144 Listeners
Biotech Hangout
18 Listeners
ASGCT Podcast Network
15 Listeners
NEJM AI Grand Rounds
52 Listeners
HBR On Leadership
162 Listeners